The annual J.P. Morgan Healthcare Conference, often called the Superbowl of biotech, kicked off on Jan. 8, 2018.
Over 450 companies will be presenting, including Celgene (CELG), Pfizer (PFE 3.59%), and Johnson & Johnson (JNJ 1.75%), and over 9,000 people (including The Motley Fool's Kristine Harjes) will be attending. But don't worry -- The Motley Fool's healthcare team will keep you informed about the most important announcements and analysis. Check back daily for updates!
- 4 Ways IBM Watson's Artificial Intelligence Is Changing Healthcare
- Here's Why Arrowhead Pharmaceuticals Inc. Is Up Today
- 7 Must-See Numbers From AbbVie's J. P. Morgan Presentation
- Rite Aid Is Outperforming the S&P 500 So Far in 2018: Here Are 5 Reasons Why
- Eli Lilly & Co. at JP Morgan: 5 Things Investors Will Want to Know
- Here's Why Novavax, Inc. Stock Shot Up Today
- Bill Gates Speaks Out on the State of Global Healthcare
- 3 Slides That Paint a Great Picture for Exact Sciences' Future
- 3 Keys for Acadia Pharmaceuticals to Succeed in 2018
- 5 Things Amgen's CEO Just Said That Investors Need to Know
- 5 Ways Gilead Sciences Plans to Return to Growth
- 5 Reasons Illumina Enjoyed a Big J.P. Morgan Conference Bounce
- Johnson & Johnson Wants to Create a Crisis -- and That's Great for Investors
- 5 Things You Need to Know From Celgene's J.P. Morgan Presentation
- 10 Things to Expect From Vertex Pharmaceuticals in 2018
- The 1 Word That Explains Why Pfizer's Future Looks Brighter Than Its Past
- Why Exact Sciences Is Tumbling Today
P.S. If you're interested in checking out how much things have changed since this time in 2017, here's last year's landing page.